James P Chandler MD
Professor, Neurosurgery, Northwestern University Medical School
Join to View Full Profile
675 N Saint Clair StGalter 2210Chicago, IL 60611
Phone+1 312-695-1065
Dr. Chandler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- James Chandler, MD, is a neurosurgeon based in Chicago, IL. He completed medical school at the University of Maryland School of Medicine in 1990, and his residency in Neurological Surgery at McGaw Medical Center of Northwestern University from 1990-1997. Dr. Chandler has published several neurosurgery-related articles in respected medical journals such as Nature Medicine, Journal of Neurosurgery, Neurosurgery, Journal of Neurological Surgery Reports, and Neurosurgical Review. His publications cover a range of topics, including surgical outcomes for older meningioma patients and targeted gene expression profiling for predicting meningioma outcomes and radiotherapy responses.
Education & Training
McGaw Medical Center of Northwestern UniversityResidency, Neurological Surgery, 1990 - 1997
University of Maryland School of MedicineClass of 1990
Certifications & Licensure
IL State Medical License 1994 - 2026
American Board of Neurological Surgery Neurological Surgery
Publications & Presentations
PubMed
- The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis.Karenna J Groff, Ruchit V Patel, Yang Feng, Hia S Ghosh, Miguel A Millares Chavez
The Lancet. Oncology. 2025-09-01 - IDH-wildtype astrocytoma with FH mutation, epigenetic similarity to IDH-mutant astrocytoma, and hypermethylation of CDKN2A arising in the brainstem.Heather L Smith, Drew J Duckett, Melissa Mejia-Bautista, Anas Alshawa, Pouya Jamshidi
Journal of Neuropathology and Experimental Neurology. 2025-07-22 - Primary papillary epithelial tumor of the sella harboring an EZH2 Y646F mutation.Jawad Fares, Pouya Jamshidi, Harrshavasan T Congivaram, Daniel Oyon, Melissa Mejia Bautista
Acta Neuropathologica. 2025-07-15
Press Mentions
Brain Tumor Benefit Celebrates Momentum Toward BreakthroughsMay 26th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
